XYLOSE
LOE Approachingxylose
NDAORALPOWDER
Approved
Mar 1987
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 13h ago · AI intelligence enriched 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Xylose is an oral powder formulation of D-xylose, a pentose sugar used as a diagnostic and therapeutic agent. The exact mechanism of action and clinical indications are not well-characterized in available data, suggesting this is a legacy product with limited modern clinical application.
LOE Approaching
With lifecycle approaching loss of exclusivity, the brand team is likely in maintenance mode with minimal growth investment and a small commercial footprint.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Xylose has zero linked job openings and represents a mature, legacy product with minimal career growth opportunity. Roles on this product focus on maintenance and compliance rather than innovation or market expansion.
Brand ManagerField Sales Representative
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.